S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/RA Capital Management/Q3 2021

RA Capital Management

Periodo: Q3 2021 Β· Depositato: 2021-11-15
Vedi su SEC EDGAR β†—
AUM
$7.22B
Valore totale del portafoglio
Posizioni
95
Titoli dichiarati
Prima Posizione
ASND
16.3% $1.18B
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-11-15) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
ASNDASCENDIS PHARMA A/S$1.18B16.32%$159.39$274.50+72.2%
16.3%
NVAXNOVAVAX INC$434.9M6.03%$207.31$9.74-95.3%
6.0%
CLYMELIEM THERAPEUTICS INC$236.4M3.28%$17.98$12.90-28.3%
3.3%
IVVDADAGIO THERAPEUTICS INC$225.6M3.13%$42.24$0.89-97.9%
3.1%
FMTXFORMA THERAPEUTICS HLDGS INC$209.0M2.90%β€”β€”
2.9%
CTKBCYTEK BIOSCIENCES INC$205.7M2.85%$21.41$4.59-78.6%
2.9%
AVIRATEA PHARMACEUTICALS INC$190.3M2.64%$35.06$4.98-85.8%
2.6%
JANXJANUX THERAPEUTICS INC$187.6M2.60%$21.63$15.54-28.2%
2.6%
VORXXXXVOR BIOPHARMA INC$174.4M2.42%β€”β€”
2.4%
AVTEAEROVATE THERAPEUTICS INC$173.4M2.40%β€”β€”
2.4%
ICVXICOSAVAX INC$171.0M2.37%β€”β€”
2.4%
DICEDICE THERAPEUTICS INC$170.6M2.36%β€”β€”
2.4%
CNTBXXXXCONNECT BIOPHARMA HLDGS LTD$169.4M2.35%β€”β€”
2.4%
NKTXNKARTA INC$155.9M2.16%$27.81$3.22-88.4%
2.2%
ABOSACUMEN PHARMACEUTICALS INC$145.2M2.01%$14.86$2.74-81.6%
2.0%
TGTXTG THERAPEUTICS INC$136.4M1.89%$33.28$53.31+60.2%
1.9%
TVTXTRAVERE THERAPEUTICS INC$136.2M1.89%$24.25$56.92+134.7%
1.9%
TYRATYRA BIOSCIENCES INC$127.3M1.76%$17.59$30.62+74.1%
1.8%
MGNXMACROGENICS INC$124.5M1.72%$20.94$4.71-77.5%
1.7%
ITOSITEOS THERAPEUTICS INC$119.3M1.65%β€”β€”
1.6%
DAWNDAY ONE BIOPHARMACEUTICALS I$117.8M1.63%β€”β€”
1.6%
IMGNIMMUNOGEN INC$104.4M1.45%β€”β€”
1.4%
PHATPHATHOM PHARMACEUTICALS INC$100.0M1.39%$32.10$11.20-65.1%
1.4%
PCVXVAXCYTE INC$98.9M1.37%$25.37$58.39+130.2%
1.4%
ETNB89BIO INC$97.3M1.35%β€”β€”
1.4%
TILINSTIL BIO INC$87.1M1.21%$357.50$7.73-97.8%
1.2%
CLDXCELLDEX THERAPEUTICS INC NEW$86.4M1.20%$53.99$38.37-28.9%
1.2%
KNTEKINNATE BIOPHARMA INC$82.7M1.15%β€”β€”
1.1%
HOWLWEREWOLF THERAPEUTICS INC$73.7M1.02%$17.16$0.34-98.0%
1.0%
TNYATENAYA THERAPEUTICS INC$73.3M1.02%$20.65$0.79-96.2%
1.0%

AttivitΓ  Trimestre su Trimestre

Q3 2021 vs. Q2 2021

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
CLYMELIEM THERAPEUTICS INC$236.4M-28.3%
IVVDADAGIO THERAPEUTICS INC$225.6M-97.9%
CTKBCYTEK BIOSCIENCES INC$205.7M-78.6%
ICVXICOSAVAX INC$171.0M
DICEDICE THERAPEUTICS INC$170.6M
ABOSACUMEN PHARMACEUTICALS INC$145.2M-81.6%
TYRATYRA BIOSCIENCES INC$127.3M+74.1%
CLDXCELLDEX THERAPEUTICS INC NEW$86.4M-28.9%

Posizioni Chiuse (8)

TickerEmittenteNozionale
AXSMAXSOME THERAPEUTICS INC$111.7M
CRISCURIS INC$57.6M
CERECEREVEL THERAPEUTICS HLDNG INC$56.4M
TRILLIUM THERAPEUTICS INC$51.3M
ARDXARDELYX INC$46.1M
LEGNLEGEND BIOTECH CORP$40.1M
INZYINOZYME PHARMA INC$34.1M
BCTGBCTG ACQUISITION CORP$14.2M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
CNTACENTESSA PHARMACEUTICALS PLC$31.3M+179.4%
EYPTEYEPOINT PHARMACEUTICALS INC$11.8M+76.8%
TGTXTG THERAPEUTICS INC$6.7M+22.6%+60.2%
ASNDASCENDIS PHARMA A/S$282.2M+8.5%+72.2%
CYTTCYTEIR THERAPEUTICS INC$-10.7M+3.2%
GHRSGH RESEARCH PLC$1.8M+1.2%
AVIRATEA PHARMACEUTICALS INC$75.0M+1.1%-85.8%
PCVXVAXCYTE INC$11.8M+0.8%+130.2%

Ridotte (6)

TickerEmittenteNozionaleVar. AzioniDal Deposito
VRDNVIRIDIAN THERAPEUTICS INC$-5.7M-99.7%
CCXICHEMOCENTRYX INC$-43.1M-93.8%
ZGNXZOGENIX INC$-40.7M-36.9%
NVAXNOVAVAX INC$-108.6M-18.1%-95.3%
ORTXORCHARD THERAPEUTICS PLC$-28.7M-10.4%
NAUTNAUTILUS BIOTECHNOLOGY INC$-10.0M-1.4%
← Torna agli Hedge Fund